Intoto Biotech
Latest round
- Series A
Last raised
- Aug 2026
Total raised
- Undisclosed
Investors
- 2
About Intoto Biotech
, trading as Intoto Biotech, operates as a provider of optical medical equipment that provides 3D pathology imaging technology platform. The company has developed a 3D pathology imaging technology platform. Its core products include the Mingzhun Pano One system, which can be used for large biological sample imaging, 3D pathology imaging, embryo, 3D cell and organoid imaging, etc. The company generates revenue by providing optical microscopy equipment.
Who invested in Intoto Biotech
2 investors across 2 rounds
See all investors in Intoto Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Intoto Biotech
Who invested in Intoto Biotech?
Intoto Biotech has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Intoto Biotech raised?
Intoto Biotech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Intoto Biotech last raise money?
Intoto Biotech's most recent round on record is a Series A, in Aug 2026.
What does Intoto Biotech do?
, trading as Intoto Biotech, operates as a provider of optical medical equipment that provides 3D pathology imaging technology platform.
Where is Intoto Biotech headquartered?
Intoto Biotech is headquartered in Fuqing, China.
Which VCs invest in companies like Intoto Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Intoto Biotech's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Intoto Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.